A disease-modifying protein therapeutic for the treatment of copd
Ended Project Grant Awarded Last action
- Award ID
- R43HL149580
- Recipient
-
Verra Therapeutics, Inc. UEI WTKNN246ZR43
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $390,914
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Funding
-
- $437,531.60 Federal
- -$46,617.62 Non-federal
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$55 | $0 | |
| Amendment | -$55 | $0 | |
| Amendment | $46,618 | $0 | |
| Amendment | $46,618 | $0 | |
| Amendment | $46,618 | $0 | |
| Amendment | -$46,618 | $0 | |
| Amendment | -$46,618 | -$46,618 | |
| Original award | $391,023 | $0 |
Quick answers
Who received award R43HL149580?
R43HL149580 was awarded to Verra Therapeutics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 15, 2019.
How much is award R43HL149580 worth?
$390,914 has been obligated on R43HL149580: $437,532 in federal funding and -$46,618 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award